Monitor for execution of definitive agreements within the 120-day timeline outlined in the LOI. Failure to reach binding terms by that date would remove the near-term catalyst. Also watch for any subsequent capital raises to fund EMAT's U.S. expansion, as the campus build-out will require substantial investment.
Price Chart
Executive Summary
EMAT entered into a non-binding letter of intent with VIVIFY Technology for a proposed strategic energy collaboration. Under the LOI, VIVIFY would serve as the primary hydrogen energy technology partner and energy-infrastructure provider for EMAT's planned U.S. rare earth magnet campus. The LOI is non-binding, contains no financial terms, and there is no assurance definitive agreements will be reached.
Key Facts
- EMAT and VIVIFY signed a non-binding letter of intent dated September 30, 2026.
- VIVIFY would provide behind-the-meter hydrogen power for EMAT's planned U.S. rare earth magnet campus.
- The LOI is non-binding except for confidentiality, publicity, securities law compliance, expenses, limitation of remedies, term, and governing law.
- No financial terms, pricing, or deal values are disclosed in the LOI.
- Definitive agreements would be conditioned on technical due diligence, commercial terms, internal approvals, site control, and governmental authorizations.
- EMAT is scaling annual magnet production capacity in Pohang, Korea from approximately 1,000 to 10,000 metric tons.
- EMAT's U.S. expansion includes rare earth refining, magnet production, recycling, and battery materials.
- VIVIFY's manufacturing in Jupiter, Florida is scheduled to begin in January 2027.
Financial Impact
No financial terms disclosed in the LOI. The collaboration is non-binding and subject to future definitive agreements.
Risk Factors
- The LOI is non-binding and there is no guarantee definitive agreements will be reached.
- VIVIFY's hydrogen systems must pass technical due diligence and independent validation.
- Site control, permitting, and governmental authorizations are required and may not be obtained.
- EMAT's U.S. expansion is subject to financing, construction, and scaling risks.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-105464 |
| Document: ea0307256-8k_evolution.htm | 0001213900-26-105464 |
| Document: ea030725601ex99-1.htm | 0001213900-26-105464 |
| Document: 0001213900-26-105464-index-headers.html | 0001213900-26-105464 |
| Document: 0001213900-26-105464-index.html | 0001213900-26-105464 |
| Document: 0001213900-26-105464.txt | 0001213900-26-105464 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $1.54 | awaiting T+20 | — | $1.43 (−7.14%) |
Oct 15, 2026 12d ago | Press Release | $1.54 | awaiting T+20 | — | $1.43 (−7.14%) |
Oct 14, 2026 13d ago | 8-K | $1.50 | awaiting T+20 | — | $1.43 (−4.67%) |
Oct 13, 2026 14d ago | EFFECT | $1.43 | awaiting T+20 | — | $1.43 (−0.35%) |
Oct 9, 2026 18d ago | 8-K | $1.64 | awaiting T+20 | — | $1.43 (−12.80%) |
Oct 8, 2026 19d ago | 3 | $1.64 | awaiting T+20 | — | $1.43 (−12.80%) |
Oct 6, 2026 21d ago | Press Release | $1.92 | awaiting T+20 | — | $1.43 (−25.52%) |
Oct 6, 2026 21d ago | 8-K | $1.92 | awaiting T+20 | — | $1.43 (−25.52%) |
Oct 6, 2026 21d ago | EFFECT | $1.92 | awaiting T+20 | — | $1.43 (+25.52%) |
Oct 5, 2026 22d ago | S-1 | $1.92 | awaiting T+20 | — | $1.43 (+25.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers